Salbutamol inhaler prescribing jumped 60% at start of COVID-19 pandemic

Experts say the increase may be owing to patients with respiratory conditions being concerned about their health during the COVID-19 pandemic; however, it comes as some manufacturers report shortages of some devices.

Pharmaceutical Journal